This webinar is the second in a three-part series exploring the use of bacteriophages and their potential as a sustainable alternative to traditional antibiotics in agriculture and animal health. This seminar follows the success of his first webinar, which focused on the opportunities and challenges faced by the application of phages to human health, and attracted an unprecedented number of over 1,300 registrations.
Bacteriophages are viruses that selectively target and kill bacteria. These are common natural entities that can destroy bacteria that are resistant to drugs such as antibiotics. Phage therapy holds promising potential in the fight against antimicrobial resistance (AMR), a major global health threat that leads to increased morbidity, mortality, and healthcare costs.
Addressing AMR requires a multidimensional approach that considers human, animal, and environmental health, known as the One Health approach. Bacteriophages represent a promising alternative or adjunct to traditional antibiotics. However, for phage therapy to potentially be adopted more widely, solid evidence supporting its efficacy, safety, and feasibility is needed across the One Health sector.
This three-part webinar series, led by WHO/Europe in collaboration with the Global Antimicrobial Resistance Research and Development Hub, aims to accelerate evidence development for bacteriophage applications within the framework of One Health. Masu.
A recording of the first webinar is available at “Vintage Innovation – Towards Building Evidence for Widespread Use of Bacteriophages from an AMR One Health Perspective.”
the purpose
The objectives of the webinar are:
- To investigate the current state of knowledge and evidence gaps regarding the use of bacteriophages for production animal applications.
- We discuss the challenges and opportunities associated with widespread introduction of phages in production animals.and
- Identify strategies to build the evidence base to support the broader use of bacteriophages as tools in the fight against AMR.
speaker
Martha Clokie, Professor of Microbiology, University of Leicester, UK
Tamta Zakareishvili, Director of Veterinary Medicine, Chilina, Georgia
Dr. Noemi García del Blanco, Head of Veterinary Biology and Emerging Therapies, European Medicines Agency, Veterinary Division, Netherlands (Kingdom)
Matthias Middelborg, Professor of Marine Biology, University of Copenhagen, Denmark
Shawon Lahiri, Senior Analyst, Joint Programming Initiative on Antimicrobial Resistance, Sweden
Please register for the webinar using the link.
